SAGE RHINO CAPITAL LLC
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1771605
MENLO PARK, CA
Position in TEVA
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$301,023
+$63,859 QoQ
Shares Held
8,885
+12.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#460
of 671 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SAGE RHINO CAPITAL LLC holds $1,801,591 across 6 Drug Manufacturers - Specialty & Generic names. TEVA ranks #2 (16.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
9,524 | $684,394 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
8,885 | $301,023 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
476 | $257,911 | |
| 4 | ALKS |
Alkermes plc.
|
4,233 | $221,809 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
11,939 | $191,382 | |
| 6 | HLN |
Haleon plc
|
15,549 | $145,072 |
All Filings in TEVA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $301,023 | 8,885 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $237,164 | 7,874 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $232,732 | 7,457 | Shares | Sole | 2026-01-30 | |
| No filing history on record for this holder in this stock. | ||||||